Treatment patterns, resource use and costs of idiopathic pulmonary fibrosis in Spain – results of a Delphi Panel

BMC Pulmonary Medicine

Table 1 Cost of management of adverse events associated with the treatment of IPF

	Non-hospitalised grade 3 adverse events^a	Grade 3 and 4 adverse events in hospitalised patients
Osteoporosis	€89.43	€3,495.47
Hyperglycaemia	€69.93	€3,898.39
Cushing syndrome	€74.66	€4,468.42
Compression fractures	€74.66	€3,495.47
Diabetes	€84.74	€3,898.39
Digestive intolerance	€68.14	€2,452.50
Opportunistic infections	€74.66	€7,085.52
Hepatotoxicity	€74.66	€2,739.44
Nausea	€68.14	€ 3,082.73
Digestive intolerance	€74.66	^b
Nasal dryness	€27.95	€1,678.20
Asthenia	^b	€3,082.73

Source: eSalud [11]
^aCosts were estimated taking into account medical visits and tests undergone by patients for their management
^bThese adverse events were reported by <5 % of patients therefore these costs were not included

ISSN: 1471-2466